Centerline Biomedical Stock

Develops imaging and navigation technology that guides minimally invasive vascular procedures with greater precision.

Buy

Buy Centerline Biomedical shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Centerline Biomedical shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Overview

Centerline Biomedical develops medical imaging and navigation technology designed to guide minimally invasive vascular procedures. The company uses advanced imaging and real-time data to help physicians visualize blood vessels and navigate devices with greater precision. Its platform aims to improve procedural accuracy, reduce complications, and enhance patient outcomes.

Sector

Healthcare & Life Sciences

Founded

2014

Headquarters

Cleveland, OH

Buy

Buy Centerline Biomedical shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Centerline Biomedical shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Centerline Biomedical Management Team

Centerline Biomedical people and management

  • Co-Founder, CTO
    Vikash Goel
  • CEO, Board Member
    Gulam Khan
  • CEO
    Jim Dillon
  • CFO
    Gregory W. Mann
  • Board Member
    Arnaud Marie
  • Board Member
    Jai N. Gupta
  • Board Member
    Jim Zalar
  • Board Member
    Michael Whitman
  • Board Member
    Mitch Wolf
  • Board Member
    Phil Rackliffe
  • Board Member
    Todd Schwarzinger
  • Board Member
    Vinod K. Goel

Investors

Major Centerline Biomedical investors

  • Cleveland Clinic

  • GE Healthcare

  • JobsOhio Growth Capital (JOGC)

  • JumpStart Ventures

Centerline Biomedical Valuations & Financials

Gain Insights Into Centerline Biomedical Stock Valuation & Share Prices

View real-time NPM data on Centerline Biomedical stock including daily Centerline Biomedical stock price estimates, valuation history, and historical share price information. Access Centerline Biomedical financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Centerline Biomedical pricing across six independent market signals. Looking for private company due diligence data sources on Centerline Biomedical? Get in touch to learn more.

Similar Companies

Explore companies

like Centerline Biomedical

  • Be Biopharma

    Healthcare & Life Sciences

    Develops engineered B cell medicines and protein-based therapies to treat serious diseases, focusing on innovative therapeutic solutions.

  • Dewpoint

    Healthcare & Life Sciences

    Develops therapies targeting protein phase transitions in cells, using biomolecular condensate technology to advance drug discovery and treatment.

  • Biobot Analytics

    Healthcare & Life Sciences

    A health data company that monitors wastewater to predict health threats, providing actionable insights for disease control and resource management.

  • Appia Bio

    Healthcare & Life Sciences

    Develops universal cell therapies using engineered iNKT cells from stem cells to create accessible, off-the-shelf treatments.

  • Persist AI

    Healthcare & Life Sciences

    Develops long-acting injectable drug formulations through screening, testing, and scale-up to solve clearance and stability issues.

  • Potrero

    Healthcare & Life Sciences

    Develops technology that monitors patient data in real time to detect complications early and support clinical decision-making.

  • Exthymic

    Healthcare & Life Sciences

    Develops decentralized cell therapy manufacturing solutions to enhance accessibility and scalability of autologous treatments.

  • ShiraTronics

    Healthcare & Life Sciences

    Develops innovative neuromodulation technology for migraine therapy, focusing on clinical testing of implantable medical devices.

  • StimAire

    Healthcare & Life Sciences

    Develops non-surgical neural stimulation technology using wearables and injectables to treat medical conditions without invasive procedures.

FAQ

Questions?

We have answers

Buy Centerline Biomedical Stock

Centerline Biomedical stock does not trade on public stock exchanges. Centerline Biomedical stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Centerline Biomedical stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Centerline Biomedical Stock

Centerline Biomedical Stock does not trade on public stock exchanges. In order to sell Centerline Biomedical shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

 

Centerline Biomedical Stock Price

Centerline Biomedical does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Centerline Biomedical share price and other valuable private market data.

Read more about secondary market private company stock prices:

Centerline Biomedical Stock Ticker Symbol

There is no ticker symbol for Centerline Biomedical stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Centerline Biomedical Stock

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Centerline Biomedical stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in Centerline Biomedical Stock

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Centerline Biomedical stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Centerline Biomedical Stock Settlement

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Centerline Biomedical IPO

Centerline Biomedical is a private company and has not had an IPO. There is currently no Centerline Biomedical IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Centerline Biomedical IPO.

Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.